newsfilter
← Latest News
GlobeNewswire·

Vor Bio Announces $150 Million Private Placement

BOSTON, Dec. 15, 2025 (GLOBE NEWSWIRE) -- Vor Bio (NASDAQ:VOR), a clinical-stage biotechnology company transforming the treatment of autoimmune diseases, announced today that it has entered into a securities purchase